Cytosorbents

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytosorbents and other ETFs, options, and stocks.

About CTSO

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb.

CEO

Phillip P. Chan

CEOPhillip P. Chan

Employees

149

Employees149

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1997

Founded1997

Employees

149

Employees149

CTSO Key Statistics

Market cap

57.87M

Market cap57.87M

Price-Earnings ratio

-4.96

Price-Earnings ratio-4.96

Dividend yield

—

Dividend yield—

Average volume

76.05K

Average volume76.05K

High today

$0.9489

High today$0.9489

Low today

$0.9002

Low today$0.9002

Open price

$0.9263

Open price$0.9263

Volume

165.95K

Volume165.95K

52 Week high

$1.61

52 Week high$1.61

52 Week low

$0.7101

52 Week low$0.7101

CTSO News

TipRanks 2d

CytoSorbents provides DrugSorb-ATR regulatory update

CytoSorbents (CTSO) provided a regulatory update on DrugSorb-ATR. CytoSorbents CytoSorbents’ flagship product, CytoSorb, is approved in the EU and distributed i...

People also own

Based on the portfolios of people who own CTSO. This list is generated using Robinhood data, and it’s not a recommendation.